This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Bove Says Sell Goldman, U.S. to 'Bleed' Firm

NEW YORK ( TheStreet) -- Rochdale Securities analyst Richard Bove has downgraded Goldman Sachs (GS - Get Report) to "sell" from "neutral," citing a Rolling Stone article and the possibility of a government fine.

Bove also cut the Goldman's price target to $120 from $163.

Dick Bove
Dick Bove

Bove said his opinion was influenced by Matt Taibbi's article in Rolling Stone titled, "The People vs. Goldman Sachs."

"How can the company do nothing about it when it is being accused of these developments?" asked Bove. "This isn't a conspiracy theory. This is backed by an investigation of the Justice Department and clearly the government wants to blame Goldman Sachs for the financial crisis."

Bove added that the downgrade was ultimately the result of article's description of U.S. Justice Department investigations into the firm. He believes that Goldman has not responded to the investigations properly and investors should drop the stock.

"The board of the company has to be reshuffled. The government is not going to get Goldman on a $1 billion settlement and it won't let up on them until they bleed," Bove said in a phone interview. "I don't want to own the stock. I don't think investors should. The company will be trading at book value"

Taibbi is also author of an infamous article on Goldman Sachs titled "The Great American Bubble Machine," published over a year ago and described Goldman Sachs as "a great vampire squid wrapped around the face of humanity."

Bove said that if Goldman Sachs CEO Lloyd Blankfein were to be replaced that someone with investment banking and law experience should replace him.

Bove could not recommend any candidates off hand.

--Written by Maria Woehr in New York.



To contact the writer of this article, click here: Maria Woehr.

To follow the writer on Twitter, go to http://twitter.com/newsgirlmw.

To submit a news tip, send an email to: tips@thestreet.com.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
GS $207.80 0.00%
AAPL $132.54 0.00%
FB $80.54 0.00%
GOOG $540.11 0.00%
TSLA $247.73 0.00%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs